[2026-01-05 21:29:15,041] [INFO] Phase 1 complete: 0 antibodies, 0 glycosites
[2026-01-05 21:29:15,236] [INFO] Phase 2 complete: 0 pairs, 0 unique lectins, 0 unique glycans
[2026-01-05 21:57:59,539] [INFO] Phase 1 complete: 497 antibodies, 895 glycosites
[2026-01-05 21:58:01,402] [INFO] Phase 2 complete: 0 pairs, 0 unique lectins, 0 unique glycans
[2026-01-05 22:09:48,650] [INFO] Phase 1 complete: 497 antibodies, 895 glycosites
[2026-01-05 22:09:50,518] [INFO] Phase 2 complete: 0 pairs, 0 unique lectins, 0 unique glycans
[2026-01-05 22:26:58,085] [INFO] Phase 1 complete: 497 antibodies, 895 glycosites
[2026-01-05 22:26:58,502] [INFO] Phase 2 complete: 0 pairs, 0 unique lectins, 0 unique glycans
[2026-01-05 22:34:11,649] [INFO] Phase 1 complete: 497 antibodies, 895 glycosites
[2026-01-05 22:34:25,742] [INFO] Phase 2 complete: 0 pairs, 0 unique lectins, 0 unique glycans
[2026-01-05 22:46:04,144] [INFO] Phase 1 complete: 497 antibodies, 895 glycosites
[2026-01-05 22:46:10,746] [INFO] Phase 2 complete: 18 pairs, 18 unique lectins, 11 unique glycans
[2026-01-05 23:07:49,560] [INFO] Phase 1 complete: 497 antibodies, 895 glycosites
[2026-01-05 23:07:49,747] [INFO] Phase 2 complete: 18 pairs, 18 unique lectins, 11 unique glycans
[2026-01-05 23:17:56,148] [INFO] Phase 1 complete: 497 antibodies, 895 glycosites
[2026-01-05 23:17:56,300] [INFO] Phase 2 complete: 18 pairs, 18 unique lectins, 11 unique glycans
[2026-01-05 23:18:32,850] [INFO] Phase 1 complete: 497 antibodies, 895 glycosites
[2026-01-05 23:18:33,010] [INFO] Phase 2 complete: 18 pairs, 18 unique lectins, 11 unique glycans
